Kidney, liver and digestive health

What Albuminuria Means and How to Read a Urine Albumin-to-Creatinine Ratio

Albuminuria means an abnormal amount of the blood protein albumin is leaking into urine, and the urine albumin-to-creatinine ratio (UACR) quantifies it from one spot sample. Read the number in milligrams per gram: under 30 is normal, 30 to 300 moderate, above 300 severe. Higher values independently predict kidney and cardiovascular risk.

Albuminuria means an abnormal amount of albumin, the most abundant protein in blood, is leaking through the kidney's filter into the urine. The urine albumin-to-creatinine ratio (UACR, also written ACR) is the standard way to measure it from a single spot sample. Reading the result is straightforward once you know the scale: the number is reported in milligrams of albumin per gram of creatinine, and it sorts into three bands, under 30 (normal to mildly increased), 30 to 300 (moderately increased), and above 300 (severely increased). A higher ratio signals damage to the kidney's filtering barrier, and pooled data from large cohorts show it predicts kidney failure and cardiovascular events independently of, and on top of, estimated glomerular filtration rate (eGFR).

What albuminuria actually measures

A healthy glomerulus, the tuft of capillaries that filters blood, holds albumin back while letting water and small waste molecules pass. When that barrier is injured by diabetes, high blood pressure, or a primary glomerular disease, albumin escapes into the urine. Because this leak often appears before eGFR falls, albuminuria is one of the earliest and most sensitive markers of kidney damage. It also reflects the health of small blood vessels throughout the body, which is why the same result carries information about the heart and circulation, not only the kidney.

Why a ratio, and how to read the number

Urine concentration swings with hydration, so a raw albumin measurement from a random sample is hard to interpret. Creatinine, a muscle breakdown product, is excreted at a fairly steady daily rate. Dividing urine albumin by urine creatinine corrects for how dilute or concentrated the sample is, letting one spot specimen approximate a full 24-hour collection. A UACR of about 45 mg/g, for example, roughly corresponds to about 45 mg of albumin lost per day.

The 2024 KDIGO guideline for chronic kidney disease anchors the three categories most labs report: A1 (under 30 mg/g), A2 (30 to 300 mg/g, the range formerly called microalbuminuria), and A3 (above 300 mg/g, formerly macroalbuminuria). Two practical points shape how a single number should be read. Albuminuria has high day-to-day variability within the same person, and a first-morning specimen tracks 24-hour excretion better than a random daytime one. Values are also transiently pushed up by strenuous exercise, upright posture, fever, urinary tract infection, very high protein intake, and menstrual contamination. For these reasons the KDIGO guideline advises that an incidental elevated UACR be repeated to confirm before it is treated as chronic kidney disease. One abnormal result is a prompt to retest, not a verdict.

Two axes are better than one

For decades, kidney disease was staged by filtration rate alone. The shift to a second axis came from the Chronic Kidney Disease Prognosis Consortium, whose 2010 collaborative meta-analysis in The Lancet pooled general-population cohorts with more than a million participants. Among those who had albumin measured, as ACR rose the risk of death and cardiovascular death climbed continuously, following a straight line when plotted on a logarithmic scale, with no clean threshold below which risk disappeared. Risk was already measurably higher at an ACR of about 10 mg/g, well inside the supposedly normal A1 band, and this held after adjusting for eGFR and traditional risk factors. Albuminuria and eGFR each carried independent, additive information.

That evidence is why KDIGO classifies chronic kidney disease on a two-dimensional grid: filtration categories G1 through G5 along one axis, albuminuria categories A1 through A3 along the other, shaded from low to very high risk. On this map, a person with a normal eGFR but A3 albuminuria can sit in a higher-risk zone than someone with a mildly reduced eGFR and no albuminuria. Reading only the eGFR would miss that.

The cardiovascular signal

The heart connection is strong and often overlooked. In a 2024 review in the Journal of the American Heart Association, Barzilay describes albuminuria as an underappreciated cardiovascular risk factor, associated with roughly a 40 percent higher risk of clinical coronary artery disease, a signal comparable in size to an elevated C-reactive protein. Albuminuria also tracks with stroke, arterial stiffness, heart failure, and arrhythmia. Notably, the risk does not switch on only at the A2 threshold. In the ARIC study cited in that review, participants with high-normal UACR values of 5 to 9 and 10 to 29 mg/g, all below the microalbuminuria cutoff, showed stepwise higher heart failure risk, and low-grade albuminuria under 30 mg/g was linked with left ventricular hypertrophy and diastolic dysfunction in hypertensive patients. The mechanism is intuitive once framed correctly: a leaking glomerulus reflects generalized endothelial and microvascular dysfunction, so protein escaping the kidney marks blood vessels that are struggling elsewhere too.

What a UACR result does and does not tell you

A UACR is a risk marker and a monitoring tool, not a standalone diagnosis. A single high value can be transient, which is why confirmation matters. Where it becomes powerful is over time: a falling ratio is one of the clearest signs that a treatment is protecting the kidney, and a rising one flags worsening prognosis before symptoms appear. Interpreted alongside eGFR, blood pressure, and the underlying cause, it turns a routine urine test into one of the most informative numbers in preventive medicine. This article is educational and not medical advice; individual results should be interpreted with a clinician who knows your full history.

References and sources

  1. KDIGO 2024 Clinical Practice Guideline for CKD (Kidney International)
  2. Barzilay, Albuminuria as a CVD Risk Factor (JAHA 2024)
  3. CKD-PC, eGFR and Albuminuria and Mortality (Lancet 2010)

How this was researched. This explainer is built from the primary sources listed above and reflects Dr. Tojjar's own critical appraisal of that evidence. It explains and evaluates research and does not provide medical care.

This article is for general education and is not medical or professional advice. For guidance about your own health, talk with a qualified clinician.

Cite this article

Tojjar, D. (2026). What Albuminuria Means and How to Read a Urine Albumin-to-Creatinine Ratio. Dr. Damon Tojjar. https://readingtheevidence.org/articles/what-albuminuria-means-uacr/

Back to all insights